US 2014/0348853 A1Published application

Methods of treating rickettsia using exchange proteins directly activated by camp (epacs) inhibitors

AssigneeBoard of Regents, The University of Texas System

InventorsBin Gong, Xiaodong Cheng, David Walker, Fang Mei

Life of this patent

Estimating the term…

Abstract

Embodiments of the invention are directed to compounds that inhibit an activity of EPAC proteins and methods of using the same.

Claims6

Dependent claims

A method for treating Rickettsia infection comprising administering an EPAC inhibitor to a subject having or at risk of having a Rickettsia infection.

Dependencies are inferred from the claim text.

Facts

Application: 14/455,325Filed 8 Aug 2014
Priority: 10 Feb 2012
Published: 27 Nov 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification5 codes

A61K 31/42
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: oxazoles
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
Y02A 50/30
In human health protection, e.g. against extreme weather: against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne…
A61K
Medicines and medical preparations

Family

Application61/597,369Us provisional application · filed 10 Feb 2012
Application14/377,574Continuation in part
Application14/455,325Continuation in part
US 2015/0110809 A1Published application
US 9,539,256 B2Related patent
US 2014/0348853 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results